EMGE had another wonderful day yesterday.
EMGE closed up over 33% over the previous close of $2.06 to $2.75 on 657,977 shares traded.
Today looks to be another great day as a release came out yesterday after the close that: Emergent Health Corp. (EMGE) Announces Pending Stock Split.
Within the release, it states that EMGE expects to review a stock split to increase shares for each share currently owned by existing shareholders.
The release also states that achieving reporting company status with the Securities and Exchange Commission is still a goal of Emergent.
Read more about the split and the entire release here.
Just to recap, EMGE is focusing current efforts on marketing licensed patent pending natural stem cell multiplying and reproducing agents capable of enhancing each individual's ability to increase their own a dult stem cells from their own bone marrow.
EMGE is working with non embryonic stem cells with success.
No comments:
Post a Comment